Device Trial Radar · NCT03381248
Cooled Radiofrequency vs. Hyaluronic Acid to Manage Knee Pain
Last checked: Nov 20, 2026Latest source record: Oct 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
177
Actual
Start
Dec 7, 2017
Primary completion
Feb 8, 2019
Study completion Jul 20, 2020
Sponsor
- Lead sponsor
- Avanos MedicalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 21, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, randomized, multicenter comparison study examining the outcomes of subjects with osteoarthritis and knee pain undergoing a procedure to create a radiofrequency lesion of the genicular nerves with the Cooled Radiofrequency Ablation (CRFA) system compared to subjects receiving Hyaluronic Acid (HA). Approximately 168 subjects will be enrolled into this study, with subjects undergoing either CRFA or HA injection in a 1:1 randomization scheme. Follow-up will be conducted for 12 months post-CRFA, with the primary endpoint being completed at month 6. Subjects randomized to the comparison (HA) group will have the option to cross-over to the neurotomy group after completing the 6-month endpoint assessment. They will be followed for an additional 6 months. Pain, overall outcome, quality of life, pain medication use, and adverse events will be compared between the two treatment groups to determine success. Subjects who were randomized to and received COOLIEF\* as their initial treatment will have the option to add 2 additional visits at 6-month intervals, representing 18 and 24 months post initial treatment.
Conditions
- Osteoarthritis of the Knee
Interventions
Cooled RadiofrequencyDevice
Delivery of energy to ablate sensory nerves via cooled radiofrequency probe.
Hyaluronic Acid InjectionOther
Delivery of hyaluronic acid into knee by injection with needle to reduce knee pain.
Crossover from Hyaluronic Acid Injection to Cooled RadiofrequencyOther
Delivery of hyaluronic acid into knee by injection with needle to reduce knee pain. After 6 months, qualifying subjects in this group will have the option to crossover to receive cooled radiofrequency treatment.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Numeric Rating Scale (NRS)Time frame: Baseline to 6 month study visit
1 more outcomes with a free account
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Lyman Medical Research
Coeur d'Alene, Idaho
9 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.